John Madden

John Madden is an accomplished professional with extensive experience in clinical outsourcing and strategic sourcing, currently serving as the Head of Clinical Outsourcing at Ultragenyx since 2023. Prior to this role, John held various leadership positions at Alexion Pharmaceuticals, including Head of R&D Alliance Management and Head of R&D Global Strategic Sourcing from 2017 to 2023. John also served as Director at Novartis from 2013 to 2017 and held significant roles at Gilead Sciences, Cross Country Healthcare, Quintiles, UCB, and PPD, showcasing a robust background in outsourcing, contracts, and commercial operations. John earned a degree from North Carolina State University.